Mitomycin C 0.02%

DRUG3 trials

Sponsors

Shahid Beheshti University of Medical Sciences, Meir Medical Center, Military Institute od Medicine National Research Institute

Conditions

MyopiaPrimary Acquired Nasolacrimal Duct ObstructionPterygium

Phase 1

Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia

Shahid Beheshti University of Medical SciencesMyopia

Start: 2009-09-30Updated: 2009-10-22

Phase 4

Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.

Meir Medical CenterPterygium

Start: 2015-09-30End: 2016-12-31Target: 62Updated: 2015-12-29

Unknown Phase

External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Primary Acquired Nasolacrimal Duct Obstruction

CompletedNCT07754058

Military Institute od Medicine National Research InstitutePrimary Acquired Nasolacrimal Duct Obstruction

Start: 2023-07-18End: 2026-03-12Updated: 2026-08-10